Vimarsana
Biggest News Aggregation in the World

Page 2 - Teva Pharm News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Teva Pharm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Teva Pharm Today - Breaking & Trending Today

Shift In Health Care Antitrust Prosecutions Is Likely - Antitrust, EU Competition - Vimarsana News

Shift In Health Care Antitrust Prosecutions Is Likely - Antitrust, EU Competition

In December 2022, the Antitrust Division of the U.S. Department of Justice and the U.S. Department of Health and Human Services' Office of the Inspector General announced a memorandum of understanding ...

Source: mondaq.com
Amici Support Reversal of PTAB Decision in CRISPR Interference | McDonnell Boehnen Hulbert & Berghoff LLP - Vimarsana News

Amici Support Reversal of PTAB Decision in CRISPR Interference | McDonnell Boehnen Hulbert & Berghoff LLP

Two amici have filed briefs in support of the appeal by Junior Party the University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, "CVC") of...

The Supreme Court Leaves Skinny Labels to Another Day | Kilpatrick Townsend & Stockton LLP - Vimarsana News

The Supreme Court Leaves Skinny Labels to Another Day | Kilpatrick Townsend & Stockton LLP

The Supreme Court recently rendered two important decisions for the biopharma industry. In the first decision, the Supreme Court ruled on enablement of genus claims for therapeutic...

Federal Circuit Holds Surgical Patent Anticipated Under Pre-AIA 35 USC102b Public Use | Allen & Overy LLP - Vimarsana News

Federal Circuit Holds Surgical Patent Anticipated Under Pre-AIA 35 USC102b Public Use | Allen & Overy LLP

This is an appeal from a District of Delaware summary judgment order that held that the asserted claims of U.S. Patent No. 9,186,208 (the ’208 Patent) are anticipated under the public...

Eastern District Of Pennsylvania Declines To Dismiss Putative Class Action Against Pharmaceutical Company - Corporate/Commercial Law - Vimarsana News

Eastern District Of Pennsylvania Declines To Dismiss Putative Class Action Against Pharmaceutical Company - Corporate/Commercial Law

The Court held that except for allegations against the company's CFO, plaintiff adequately alleged misrepresentations, scienter, and loss causation.

Source: mondaq.com